$GTBIF

Green Thumb Industries Inc.

Green Thumb Industries manufactures and distributes cannabis consumer packaged goods and operates cannabis retail stores. Its Consumer Packaged Goods business grows and processes cannabis and produces products including flower, pre-rolls, concentrates, vapes, tinctures, edibles and topicals under brands such as &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. Green Thumb licenses these brands and pays license fees for their use. It sells branded products to third-party licensed retailers and through its own stores. Its Retail business, including the RISE Dispensaries chain and stores under other names, sells Green Thumb products and third-party cannabis products to patients and customers. Green Thumb is headquartered in Chicago, Illinois, and operates in fourteen U.S. markets. As of December 31, 2025, it has 113 open and operating retail locations.

0
1
0

No SEC Form 4 filings for $GTBIF in the last 30 days.

See all $GTBIF insider activity →

Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?

Green Thumb Industries (GTBIF) reported its first quarterly loss since 2025, with a $0.02 per share loss in Q3 2026, despite an 11.3% year-over-year revenue increase to $324.4 million. The company continues to grow sales and maintain financial discipline, with $58 million in operational cash flow and share buybacks totaling $77.7 million. Green Thumb is expanding in high-growth states and remains a stable bet in the cannabis industry, with a lower debt-to-EBITDA ratio compared to peers.

Green Thumb Industries Inc (GTBIF) (Q3 2026) Earnings Call Highlights: Revenue Climbs 11%

Green Thumb Industries (GTBIF) reported Q3 2026 revenue of $324M, up 11% YoY, with normalized EBITDA at $89M. Same-store sales grew 3%, and cash flow from operations was $58M. The company faces pricing pressure and regulatory uncertainty, with Q4 revenue expected to be flat. CEO Ben Kovler emphasized caution in capital allocation due to uncertainty. The company is expanding in markets like Virginia, Texas, and Florida, with plans for 3-5 Florida stores by year-end and 10+ in 2027.

GTBIF sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning GTBIF (Green Thumb Industries Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent GTBIF coverage spans earnings and financial news.

What's driving GTBIF

  • Improving same-store sales and cash generation support the bull case, but margin compression and net loss keep downside risk elevated.

    finance.yahoo.com · Nov 16, 2026

  • Earnings miss may trigger short-term price decline despite solid cash flow.

    finance.yahoo.com · Nov 8, 2026

  • Green Thumb Industries (GTBIF) reported Q3 2026 revenue of $324M, up 11% YoY, with normalized EBITDA at $89M. Same-store sales grew 3%, and cash flow from operations was $58M. The company faces pricing pressure and regulatory uncertainty, with Q4 revenue expected to be flat. CEO Ben Kovler emphasized caution in capital allocation due to uncertainty. The company is expanding in markets like Virginia, Texas, and Florida, with plans for 3-5 Florida stores by year-end and 10+ in 2027.

    finance.yahoo.com · Nov 7, 2026

  • Earnings show revenue growth but a small net loss, suggesting modest upside potential if investors focus on top‑line momentum.

    SEC EDGAR 8-K · Nov 4, 2026

  • Strong profitability and cash generation suggest upside, but recent cash flow decline introduces caution.

    finance.yahoo.com · Oct 30, 2026

AlphAI scores every news story that mentions GTBIF with an AI model for sentiment and relevance, and aggregates insider trades from Green Thumb Industries Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $GTBIF

Score

Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?

Green Thumb Industries (GTBIF) reported its first quarterly loss since 2025, with a $0.02 per share loss in Q3 2026, despite an 11.3% year-over-year revenue increase to $324.4 million. The company continues to grow sales and maintain financial discipline, with $58 million in operational cash flow and share buybacks totaling $77.7 million. Green Thumb is expanding in high-growth states and remains a stable bet in the cannabis industry, with a lower debt-to-EBITDA ratio compared to peers.

Green Thumb Industries Inc (GTBIF) (Q3 2026) Earnings Call Highlights: Revenue Climbs 11%

Green Thumb Industries (GTBIF) reported Q3 2026 revenue of $324M, up 11% YoY, with normalized EBITDA at $89M. Same-store sales grew 3%, and cash flow from operations was $58M. The company faces pricing pressure and regulatory uncertainty, with Q4 revenue expected to be flat. CEO Ben Kovler emphasized caution in capital allocation due to uncertainty. The company is expanding in markets like Virginia, Texas, and Florida, with plans for 3-5 Florida stores by year-end and 10+ in 2027.

$GTBIFMedEarnings

Green Thumb Industries Reports Third Quarter 2026 Results

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Green Thumb Industries Reports Third Quarter 2026 Results CHICAGO and VANCOUVER, British Columbia, November 4, 2026 – Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis company with a portfolio of best

President Trump's Push to Reschedule Marijuana Hit a Snag. Is Green Thumb Still a Buy?

Green Thumb Industries (GTBIF) faces delays in marijuana rescheduling, which could ease its federal tax burden. Despite this, the company reported Q2 2026 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The stock trades at $6.40, with a market cap of $1.4B. The company is using buybacks to reduce shares outstanding, but risks include pricing pressure and regulatory uncertainty.

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

Related tickers